ABSTRACT A GFP expression screen has been conducted on .1000 Janelia FlyLight Project enhancerGal4 lines to identify transcriptional enhancers active in the larval hematopoietic system. A total of 190 enhancers associated with 87 distinct genes showed activity in cells of the third instar larval lymph gland and hemolymph. That is, gene enhancers were active in cells of the lymph gland posterior signaling center (PSC), medullary zone (MZ), and/or cortical zone (CZ), while certain of the transcriptional control regions were active in circulating hemocytes. Phenotypic analyses were undertaken on 81 of these hematopoieticexpressed genes, with nine genes characterized in detail as to gain-and loss-of-function phenotypes in larval hematopoietic tissues and blood cells. These studies demonstrated the functional requirement of the cut gene for proper PSC niche formation, the hairy, Btk29A, and E2F1 genes for blood cell progenitor production in the MZ domain, and the longitudinals lacking, dFOXO, kayak, cap-n-collar, and delilah genes for lamellocyte induction and/or differentiation in response to parasitic wasp challenge and infestation of larvae. Together, these findings contribute substantial information to our knowledge of genes expressed during the larval stage of Drosophila hematopoiesis and newly identify multiple genes required for this developmental process.
cells, the JAK/STAT, Hedgehog (Hh), Insulin-like receptor (InR), Wingless (Wg), Pvf/Pvr, and fibroblast growth factor (FGF) pathways and ROS signaling are key regulators (Benmimoun et al. 2012; Martinez-Agosto 2012, 2013; Krzemień et al. 2007; Mandal et al. 2007; Mondal et al. 2011 Mondal et al. , 2014 Owusu-Ansah and Banerjee 2009; Shim et al. 2012; Sinenko et al. 2009 ). In addition, our previous work has shown that the germ line differentiation factor bag-of-marbles (bam) and microRNA-7 (mir-7) cooperatively regulate blood progenitor cells and their differentiation (Tokusumi et al. 2011) . In the PSC, two transcription factors, Antennapedia (Antp) and Knot/ Collier (Col), play important roles in PSC development and maintenance (Krzemień et al. 2007; Mandal et al. 2007) . Col likewise functions in a cell-autonomous manner to maintain the hematopoietic progenitor population (Benmimoun et al. 2015) . The Decapentaplegic (Dpp), InR, Wg, and Slit/Robo signaling pathways are also key regulators of PSC size and organization (Benmimoun et al. 2012; Morin-Poulard et al. 2016; Pennetier et al. 2012; Sinenko et al. 2009; Tokusumi et al. 2012 Tokusumi et al. , 2015 .
Differentiation of hematopoietic progenitors can generate three mature blood cell types in Drosophila (Figure 1 , C-E): plasmatocytes, crystal cells, and lamellocytes (Evans et al. 2003) . Plasmatocytes are small round cells with phagocytic capacity and they constitute the majority of circulating hemocytes. Crystal cells carry prophenol oxidase, which is involved in melanization. Lamellocytes are large flat adherent cells that are rare under normal developmental and physiological conditions. However, under challenge conditions such as wasp parasitization, numerous lamellocytes are induced, wherein they function to encapsulate the foreign invader. In this study, we crossed . 1000 Janelia FlyLight Project enhancer-Gal4 lines with the UAS-GFP reporter line and documented GFP expression patterns in both lymph glands and larval hemolymph. Enhancer activity was classified as to the positive hemocyte expression type (plasmatocyte, crystal cell, and/or lamellocyte) and distinct cell-specific expression in domains of the lymph glands (CZ, MZ, PSC, and/or posterior lobes). These studies provided a wealth of information on gene enhancers that are active in cells of the larval hematopoietic system, and multiple associated genes were further studied and shown to be essential for proper hematopoiesis in normal or wasp-challenged larvae.
MATERIALS AND METHODS

Fly and wasp lines
Enhancer-Gal4 lines of the Janelia FlyLight Project (http://flweb.janelia. org/), UAS-RNAi TRiP lines, UAS-GFP, UAS-mCD8::GFP, Pxn-Gal4, UAS-E2f1 UAS-Dp, and UAS-E2f1 PIP-3A were obtained from the Bloomington Drosophila Stock Center. The TepIV-Gal4 line was obtained from the DGRC (Kyoto, Japan). We also used the following fly strains: domeMESO (dome-lacZ) (Hombria et al. 2005) ; eater-GFP ); MSNF9-mCherry (Tokusumi et al. 2009a) ; Pcol85 (Krzemień et al. 2007) ; UAS-FOXO, dFOXO 21 , and dFOXO 25 (Junger et al. 2003) ; UAS-cncB (Veraksa et al. 2000) ; UAS-cncC (Sykiotis and Bohmann 2008) ; and puc E69 kay 1 and kay 2 (Zeitlinger and Bohmann 1999) . To generate BcF6-mCherry lines, we subcloned the BcF6 DNA regulatory region into pmCherry Pelican, injected w 1118 embryos, and generated transgenic lines (Gajewski et al. 2007; Tokusumi et al. 2009a) . Hymenoptera wasp L. boulardi, strain Lb17, was provided by T. A. Schlenke and S. Govind (Schlenke et al. 2007 ).
Tissue immunostaining
Lymph gland immunostaining was performed as previously described (Tokusumi et al. 2011) . The following primary antibodies were used: mouse anti-Antp (1:100; 4C3, Developmental Studies Hybridoma Bank), anti-b-Galactosidase (1:100; Promega), and mouse anti-NimC1 antibody (Vilmos et al. 2004) (1:100; I. Ando). As secondary antibodies, we used the Alexa 555-conjugated anti-mouse IgG antibody (Invitrogen). We analyzed stained samples with a Zeiss Axioplan Fluorescence microscope or a Nikon AR-1 laser-scanning confocal microscope. Data were collected from at least 10 third instar larvae in all enhancer expression or gene phenotype analyses experiments.
Wasp infestation
Parasitoid wasp Leptopilina boulardi strain Lb17 was reared in Drosophila w 1118 flies (Schlenke et al. 2007) . Infestation experiments were performed as described previously (Sorrentino et al. 2002) . Briefly, 36-48 hr old larvae were exposed to 8-10 female wasps for 24 hr at 25°, left for 2 d at room temperature, and dissected. As shown in Figure 7 , lymph glands were categorized by three levels of MSNF9mCherry-positive cells as it was difficult to count lamellocytes precisely due to their aggregation.
Data availability
FlyLight Project GAL4 lines are available from the Bloomington Drosophila Stock Center. Several lines used in this study are maintained in our lab and available upon request. Both BcF6mCherry and MSNF9mCherry fly lines are available upon request.
RESULTS AND DISCUSSION
Enhancer-Gal4 line screening strategy The Janelia FlyLight Project has generated transgenic Gal4 lines containing $7000 enhancers from $1200 genes (Jenett et al. 2012; Pfeiffer et al. 2008) . Previously, we performed a microarray analysis of RNAs present in lymph glands and confirmed at least 8000 genes being active in this larval hematopoietic organ (Tokusumi et al. 2011) . Approximately 400 lymph gland-expressed genes overlap with those analyzed in the FlyLight Project and there are $3000 enhancer-Gal4 lines related to these genes. We chose to study transcription factor and signaling pathway genes, selected 206 genes/1096 enhancer-Gal4 lines for analysis, and crossed these strains with UAS-GFP flies to monitor resulting Gal4 activity patterns in at least 10 larvae (Supplemental Material, Table  S1 ). We identified 190 enhancers that can direct GFP reporter gene expression in larval blood tissues, including lymph glands and hemolymph. These findings are summarized in Figure 1 and Table S2 . Among the larval blood cell-positive enhancer-Gal4 strains, 144 lines were expressed in cells present in the primary lobes of the lymph glands, whereas 81 lines showed enhancerGal4 activity in cells of the hemolymph and/or sessile hemocytes (Figure 1 , F and G).
PSC-expressed enhancer-Gal4 lines:
We identified 48 lines with enhancer-Gal4 activity in the PSC domain of the lymph gland. Of these, 19 enhancers induced Gal4 expression solely in PSC cells, whereas 29 other enhancer-Gal4 combinations were expressed in both the PSC and other cells present within the primary lymph gland lobes ( Figure 1F , Figure S1 , and Table S2 ). For examples from the former group, enhancer-Gal4 expression in lymph glands from the GMR13A11, GMR34E03, and GMR53G07 strains (Figure 2 , A-C) was highly consistent with Antp-positive PSC cells, while enhancer-Gal4 activity in tissues from the GMR56G04, GMR45A01, GMR66A05, GMR59N01, and GMR57A11 lines (Figure 2 , D-H) overlapped with a subset of Antp-positive PSC cells. The efficacy of this screen could be immediately assessed as the GMR13A11 strain showed the expression of a kn/ col gene enhancer in PSC cells, with the Col transcriptional regulator known to function in PSC and hematopoietic progenitor population maintenance (Benmimoun et al. 2015 : Krzemień et al. 2007 . Likewise, the GMR53G07 and GMR59N01 strains show the activity of dally-like (dlp) and dally gene enhancers in niche cells, consistent with the function of these Dpp signaling pathway genes in PSC size control and organization (Morin-Poulard et al. 2016; Pennetier et al. 2012) . The implication is that other PSC-expressed enhancers are likely associated with genes that function in some manner in cells of the hematopoietic niche.
In addition, we identified three enhancer regions that directed Gal4 activity in PSC cells post-wasp egg infestation, but not under normal developmental conditions. Specifically, the GMR44C05 and GMR44B09 strains associated with the longitudinals lacking (lola) gene possessed enhancers active in CZ cells in control animals ( Figure 2I ), but wasp parasitization resulted in induced GFP expression in PSC cells while also causing a reduction in CZ cell number ( Figure 2J and Figure S1 ). Comparably, the GMR36G01 strain contains an enhancer associated with the cap-n-collar (cnc) gene. This enhancer is inactive in cells of the lymph gland of wild-type third instar larvae ( Figure 2K ), but the enhancer activates GFP expression in PSC cells and lamellocytes postwasp challenge ( Figure 2L ). Thus, the cnc gene may be a locus that is induced in niche cells and defensive lamellocytes upon wasp infestation, warranting an analysis of its function in the hematopoietic system under this means of physiological stress to third instar larvae.
MZ-expressed enhancer-Gal4 lines:
We identified 47 Gal4 lines that showed GFP reporter gene expression in the MZ domain ( Figure 1F ). Among these lines, 12 enhancer regions induced the reporter gene exclusively in MZ cells ( Figure S1 and Table S2 ). We observed that enhancers present in the GMR47F05, GMR12H06, GMR36B11, and GMR50A12 lines drove the GFP reporter strongly in MZ cells marked by domeMESO expression (Figure 3 , A-D). These MZ-active enhancers are associated with genes encoding the E2f1, Hairy (H), Zfh-1, and Hnf4 transcriptional regulators, with functional studies documenting an importance for these protein factors in MZ cell production or maintenance (discussed below). The GMR13B08 strain, which contains an enhancer DNA located in an intron of the col gene, showed weak GFP expression in cells of both the MZ and PSC domains ( Figure 3E ). Again, pertaining to the efficacy of the current screen, a recent report demonstrated that the Col transcriptional regulator is weakly expressed in MZ cells, where it is known to function in the maintenance of blood progenitor cells (Benmimoun et al. 2015) . Thus, this may be the genomic DNA region that is responsible for Col expression in this lymph gland domain.
It should be noted that the MZ is composed of both core blood cell progenitors (Benmimoun et al. 2015; Oyallon et al. 2016 ) and more peripheral intermediary progenitors (Krzemien et al. 2010; Tokusumi et al. 2011) . In testing for enhancers active in this lymph gland domain, we utilized the commonly used domeMESO (dome-lacZ) marker, which is expressed in the majority of MZ cells but not in all Yanpositive intermediary cells. Thus, our findings do not readily discriminate between enhancers that are active in core progenitors and/or intermediary progenitors.
CZ and hemolymph blood cell-expressed enhancer-Gal4 lines: We identified 105 lines with enhancer-Gal4 activity in the CZ domain of the primary lymph gland, which is composed of differentiating or mature blood cells ( Figure 1F ). Among these, 72 lines showed GFP expression exclusively in CZ cells. We observed that enhancers present in the GMR76B06, GMR41D08, GMR10F02, GMR45B09, GMR81C08, and GMR87G09 strains drove the GFP reporter strongly in CZ cells, peripheral to MZ cells marked by domeMESO expression (Figure 4 , A-F). These six enhancer DNAs are associated with the bun, chinmo, dm, pnt, Kr-h1, and shn genes, respectively, all of which encode transcription factors of different structural domain classes.
Colabeling of GFP with the crystal cell marker BcF6mCherry allowed for the identification of enhancers that were active in differentiating or mature crystal cells. The GMR30A01 enhancer corresponds to a genomic DNA located in an intron of the Notch gene. GFP expression in lymph glands from this line is expressed in BcF6-mCherry-labeled crystal cells ( Figure 4G ), but also a few plasmatocytes marked by an anti-NimC1 antibody (Table S2 ). GMR86E04 contains an enhancer derived from the klumpfuss (klu) gene, GMR67A02 contains an enhancer of the regular (rgr) gene, and GMR10G12 an enhancer from the Myc/dm gene. All three genes encode transcriptional regulators and the corresponding lines showed clear GFP expression in crystal cells (Figure 4 , H-J) and also in circulating plasmatocytes (Table S2) . It is interesting that the Notch and Myc/dm enhancers are active in crystal cells as the latter gene contains genomic DNA regions that contain Notchresponse elements that are bound by Su(H) transcriptional regulator (Terriente-Felix et al. 2013 ). In addition, we found that the GMR39C04 strain, which contains an enhancer DNA associated with the Sox102F gene, directed GFP expression in crystal cells ( Figure 4K ). This line also showed GFP expression in circulating plasmatocytes (Table S2) .
A total of 81 lines showed GFP expression in blood cells of the hemolymph of third instar larvae ( Figure 1G ), and most showed GFP reporter expression in both lymph gland CZ cells and hemolymph blood cells. One interesting strain was GMR40F10, containing an enhancer associated with the bobby sox (bbx) gene, which encodes an HMG box class transcription factor. GFP expression was observed in circulating plasmatocytes ( Figure 4L ), but not in any cells of the lymph glands (Table S2) , making this a unique strain and enhancer discovered in this screen.
Finally, we identified 43 lines that showed GFP expression in lamellocytes induced upon wasp infestation and 11 that showed exclusive expression only in this blood cell type. Three examples are given in Figure 5 , wherein the enhancer-Gal4 combinations were inactive in control lymph glands but induced to high activity levels in lamellocytes post-wasp infestation. These included GMR60B06 (enhancer from the dFOXO gene), GMR42E11 [enhancer from the kayak (kay) gene], and GMR39F12 [enhancer from the delilah (dei) gene] ( Figure 5 , A-F). These three genes encode transcription factors and the specific de novo induction that results suggests a role for one or more of these regulators in the production of the defensive lamellocyte population in response to parasitic wasp challenge to larvae.
Functional analyses of enhancer-associated genes
We identified 190 enhancers that showed activity in cells of the larval hematopoietic system, with these transcriptional regulatory regions associated with 87 distinct genes. The hematopoietic functions of some of these genes have been previously documented, but the functions of many of the blood cell-active genes identified in this screen have not been described. Therefore, we undertook phenotypic analyses of 81 of these genes using gain-and loss-of-function approaches possible with the Gal4-UAS gene expression system (summarized in Table 1, Table 2,  Table 3, and Table S3 ). We collected data from at least 10 larvae of each genotype. The hematopoietic functions of nine of these genes are presented in more detail as follows.
cut (ct):
The GMR34E03 line showed strong GFP reporter expression in PSC cells ( Figure 2B ). This line contains an enhancer corresponding to ct gene DNA. PSC-specific knockdown of ct function by col-Gal4 . UAS ct RNAi expression resulted in a strong overproduction of PSC cells ( Figure 6B ). Conversely, gain-of-function ct due to col-Gal4 . UAS ct expression led to a decrease in PSC cell number (Table 1) . Thus, the homeobox protein Ct appears to play a negative role in the production and/or proliferation of PSC niche cells. Interestingly, CUX1 is a human homolog of Drosophila ct that functions as a haploinsufficient tumor suppressor gene inactivated in acute myeloid leukemia (McNerney et al. 2013) . This same study showed that haploinsufficiency of ct led to hemocyte overproliferation and melanotic tumor formation in Drosophila larvae. Thus, Ct has been identified in two studies as being an important hematopoietic factor negatively controlling PSC cell and hemocyte production. longitudinals lacking (lola): The GMR44C05 line failed to show GFP expression in lymph gland PSC cells isolated from third instar larvae grown under normal conditions ( Figure 2I ). However, upon wasp challenge, GMR44C05 lymph glands showed a de novo reporter expression in PSC cells ( Figure 2J ). This line contains an enhancer corresponding to lola gene DNA. We have previously identified lola as a positive regulator of PSC formation based on its RNAi knockdown phenotype (Tokusumi et al. 2012) . In this study, we further confirmed an importance for the BTB class transcriptional regulator in PSC cells in that gain-of-function lola due to col-Gal4 . UAS lola expression led to a strong increase in PSC cell number ( Figure 6D ). Strikingly, this forced expression of Lola, specifically in PSC cells, led to a copious production of lamellocytes in otherwise wild-type lymph glands ( Figure 6D ). This latter finding suggested that Lola may be inducing a signaling molecule(s), secreted from niche cells, that leads to lamellocyte production and differentiation (Crozatier et al. 2004; Krzemień et al. 2007; Sinenko et al. 2012) .
hairy (h):
The GMR12H06 line showed GFP expression in MZ cells marked by domeMESO ( Figure 3B ). This line contains an enhancer corresponding to h gene DNA. h is best known as a pair rule gene controlling embryonic segmentation. MZ cell-specific knockdown of h function by TepIV-Gal4 . UAS h RNAi expression resulted in a total loss of the Tep IV-positive prohemocyte population ( Figure  6F ). H is known to function as a transcriptional repressor through its interactions with corepressor proteins like CtBP and Groucho (Abed et al. 2011; Poortinga et al. 1998 ). These results implicated h as being involved in hemocyte progenitor quiescence by repressing genes that promote the differentiation of hemocytes. Btk family kinase at 29A (Btk29A): The GMR26D06 line showed GFP expression in a subset of MZ cells marked by domeMESO ( Figure  3F ). This line contains an enhancer corresponding to the Btk29A gene, which encodes a Btk class protein kinase (Hamada-Kawaguchi et al. 2014). MZ cell-specific knockdown of Btk29A function by TepIVGal4 . UAS Btk29A RNAi expression resulted in a strong reduction of the TepIV-positive MZ cell population ( Figure 6G ). These results suggested that Btk29A kinase is expressed in cells of the MZ domain, where it may function in a signaling cascade facilitating the production of prohemocytes.
dFOXO: The GMR60B06 line contains an enhancer from the dFOXO gene and failed to express the GFP reporter in lymph glands isolated from control third instar larvae ( Figure 5A ). However, when animals of this genotype were subjected to wasp challenge, the dFOXO enhancer was strongly activated in lamellocytes ( Figure 5B ). We confirmed the requirement of FOXO function for lamellocyte induction due to wasp infestation ( Figure 7A ). In addition, we demonstrated that forced expression of FOXO in Pxn + hemocytes via Pxn-Gal4 . UAS dFOXO expression resulted in an induction of lamellocytes in lymph glands and hemolymph ( Figure 6I and data not shown). Thus, a dFOXO enhancer is activated in lamellocytes, this transcriptional regulator is required for a full lamellocyte induction in response to wasp parasitization, and FOXO can dominantly induce the defensive lamellocyte population when expressed in an otherwise wild-type lymph gland.
kayak (kay):
The GMR42E11 line contains an enhancer from the kay gene that, like the dFOXO GMR60B06 line, failed to express GFP in control lymph glands ( Figure 5C ). In addition, like the dFOXO enhancer, the kay enhancer was activated in lamellocytes induced upon wasp infestation ( Figure 5D ). kay encodes the Drosophila homolog of the mammalian Fos transcription factor, which is a proven proto-oncogene and known target of JNK pathway signaling. Previous studies from our lab have demonstrated that kay function is required for the activity of a lamellocyte-specific enhancer of the misshapen (msn) gene and that kay haploinsufficiency reduces hop Tum2l -induced lamellocyte production (Tokusumi et al. 2009b ). Other previous studies have shown that forced kay expression can dominantly induce lamellocytes n n Table 3 Summary of transcriptional enhancers active in CZ cells, hemolymph blood cells, or lamellocytes, and phenotype analyses of their associated genes
RNAi, RNA interference; GOF, gain-of-function; NE, no effect; LM, lamellocyte production; LM ;, decrease lamellocytes under wasp infestation. a UAS-cncB. b UAS-cncC. (Stofanko et al. 2008) . In this study, we further demonstrated that kay function knockdown by Pxn-Gal4 . UAS kay RNAi expression led to a strong reduction in lamellocyte production post-wasp infestation, and that the transheterozygous kay 1 puc E69 /kay 2 mutant combination led to a complete absence of lamellocyte induction under these wasp challenge conditions ( Figure 7A ; Ciapponi and Bohmann 2002) . Together, these findings demonstrated that a kay enhancer is activated in waspinduced lamellocytes, the dFos transcription factor is required for the activity of the lamellocyte-specific msn enhancer, kay function is required for lamellocyte induction in response to wasp challenge, and forced gene expression can induce the defensive lamellocyte population in lymph glands.
cap-n-collar (cnc): As noted previously, the GMR36G01 line contains an enhancer from the cnc gene, with this enhancer inactive in cells of control lymph gland ( Figure 2K ). However, upon wasp challenge, this enhancer becomes active in PSC cells and defensive lamellocytes ( Figure 2L ). The cnc gene produces three mRNA isoforms: cncA, cncB, and cncC (McGinnis et al. 1998) . Interestingly, forced expression of either cncB ( Figure 6J ) or cncC isoforms in Pxn-positive hemocytes resulted in a copious production of lamellocytes. In support of the role of one or more cnc isoforms in lamellocyte differentiation, cnc function knockdown of all isoforms by Pxn-Gal4 . UAS cnc RNAi expression resulted in a strong reduction of lamellocyte induction in response to wasp infestation ( Figure 7A ). Thus, like dFOXO and kay, cnc is a gene possessing an enhancer that is activated in response to wasp challenge to larvae, two mRNA isoforms can dominantly induce the lamellocyte lineage, and gene function is required for a defensive cellular immune response to wasp parasitization.
delilah (dei):
The GMR39F12 line contains an enhancer from the dei gene and failed to express GFP in any cells of control lymph glands ( Figure 5E ). But, as seen with the GMR60B06 (dFOXO enhancer) and GMR42E11 (kay enhancer) strains, the dei enhancer became activated in lamellocytes in response to larval wasp challenge ( Figure 5F ). Additionally, we demonstrated that knockdown of dei function led to a strong decrease in lamellocyte production in response to wasp infestation ( Figure 7A ). dei encodes a bHLH-class transcription factor shown to be important for the expression of a bPS integrin subunit required for proper wing formation (Egoz-Matia et al. 2011) . The same subunit is expressed in lamellocytes, and the Dei transcription factor may likewise be crucial for integrin gene expression and lamellocyte differentiation. Lamellocytes also express the aPS4 integrin, but the function of these integrin subunits in these blood cells has yet to be investigated (Stofanko et al. 2010 ).
E2F transcription factor 1 (E2f1): E2F1 is a transcription factor involved in cell cycle control and numerous studies have shown that this protein interacts with the DP protein, with the E2F1/DP heterodimeric transcription factor complex positively regulating many genes required for initiation of S phase of the cell cycle. We have previously demonstrated that this regulator controls PSC cell number through its direct or indirect activation of the dMyc cell proliferation gene (Tokusumi et al. 2015) . In the current study, it was confirmed that E2f1 loss-of-function via col-Gal4 . UAS-E2f1 RNAi expression resulted in a strong decrease in PSC cell number, while E2f1 gain-offunction via col-Gal4 . UAS E2f1 expression culminated in a significant increase in niche cells (Table 1) . Thus, a clear function for this gene has been established in the control of PSC cell number. It was of interest that we also observed GFP expression in MZ cells in the GMR47F05 line ( Figure 3A ), as this line contains an enhancer corresponding to E2f1 gene DNA. To test for a possible function of the E2F1 regulator in these blood cell progenitors, we again conducted gene gain-and loss-of-function analyses. As for cell-specific loss-of-function mediated by RNAi expression, the abrogation of either E2f1 or Dp functions resulted in a complete loss of the TepIV-positive prohemocyte pool (Figure 8 , B and C). Conversely, forced expression of a UAS-E2f1 cDNA in MZ cells resulted in a robust overproduction of hematopoietic progenitors ( Figure 8E ). Even more dramatic was the result obtained with the coexpression of E2f1 and Dp under the control of the TepIVGal4 driver: a massive expansion of pluripotent prohemocytes and the copious induction of lamellocytes as well ( Figure 8F ). Thus, this expression combination increased both the hematopoietic progenitor population and induced specialized hemocytes involved in innate immune responses. One explanation is that the level of the activating E2F1/DP transcription factor complex was elevated relative to the level of the inhibitory RBF protein. Together, these findings suggested the importance of the E2F1 and DP cell cycle regulators for hematopoietic progenitor production and maintenance, and the positive control of lamellocyte induction.
Conclusions
We have undertaken an extensive screen for enhancer-Gal4 lines that are active in cells of the larval hematopoietic organ and in differentiated hemocytes. A total of 190 enhancers associated with 87 genes were shown to be expressed in cells of the larval lymph gland and/or blood cells of the larval hemolymph. Although we believe that many Gal4 lines are an accurate indicator of enhancer-associated gene expression, Gal4 expression patterns may sometimes differ from RNA patterns detected by in situ hybridization or protein expression by antibody immunostaining. Thus, they may not fully reflect actual gene expression. Therefore, in future studies, it may be wise to confirm enhancer activity with additional gene expression analyses such as RNA and/or protein detection in lymph glands for a gene of interest.
Most of the 87 genes were analyzed for hematopoietic phenotypes through gain-and/or loss-of-function studies. Except for a few genes, we mainly used RNAi lines in gene loss-of-function analyses. It is noted that this approach may occasionally be prone to off-target effects, so a detailed analysis of the function of a gene in hematopoietic cells would benefit from the phenotypic analysis of gene mutants. Nonetheless, we have found multiple examples of the cellular location of enhancer activity being consistent with the loss-of-function phenotype generated through the use of a genespecific RNAi reagent. Select highlights of these expression and phenotype analyses are elaborated as follows.
Numerous enhancer-Gal4 lines have been identified that are expressed exclusively in PSC cells, MZ cells, or mature hemocytes of the CZ or hemolymph. On occasion, one may try to utilize a certain supposed tissuespecific enhancer for gene gain-or loss-of-function studies, but due to unfortunate activity of the said enhancer in additional cells, the driverexpression combination may result in lethality prior to a developmental time point of interest. With the identification of multiple cell-specific enhancer-Gal4 lines in the current study, the experimental repertoire of hematopoietic system genetic tools has been substantially increased.
Several unique enhancer-Gal4 lines were discovered in this screen. One is the GMR40F10 strain, which contains an enhancer from the bbx gene ( Figure 4L ). This enhancer-Gal4 combination is active in blood cells of the hemolymph but not in lymph gland CZ hemocytes. Using this driver and a cell death-inducing gene such as UAS-hid, one can selectively ablate hemolymph blood cells while leaving the lymph gland population unharmed. The effect of eliminating this functionally distinct blood cell population and tissue (Leitão and Sucena 2015; Markus et al. 2009 ) can be assayed for in larvae grown under normal vs. physiologically challenged conditions.
The current study allowed us to identify the lola gene as a potent regulator of lamellocyte induction and differentiation. Previous work from our lab had shown that lola functioned as a positive regulator of PSC formation (Tokusumi et al. 2012) , and the current analysis demonstrated that a lola enhancer in the GMR44C05 strain was activated in niche cells upon wasp parasitization of larvae ( Figure 2J) . Surprisingly, forced expression of the Lola BTB class transcription factor in PSC cells led to a copious production of lamellocytes in otherwise normal lymph glands ( Figure 6D ). It has been shown that Spitz is a cytokine factor secreted from oxidatively challenged PSC niche cells, where it functions to induce lamellocyte production from CZ cells (Sinenko et al. 2012) . It is possible that forced Lola expression leads to Spitz and/or another cytokine factor that signals from the PSC niche to promote CZ cells to undergo lamellocyte differentiation. Making this connection would provide informative mechanistic information as to how lola is controlling the induction of this defensive cell type.
Lamellocyte production serves as a cellular innate immune response to wasp infestation of Drosophila larvae. The current study identified, or further supported, the requirement of four genes for a competent defensive response to wasp challenge. These include the dFOXO, kay, cnc, and dei genes. Coupled with our findings on lola, these results indicate that lamellocyte production in response to wasp parasitization is a genetically complex larval response. The cellular origin of lamellocytes has been investigated, with some results implicating plasmatocytes as the source (Honti et al. 2010; Stofanko et al. 2010) . Other findings point to the crystal cell lineage as the origin (Ferguson and Martinez-Agosto 2014; Krzemien et al. 2010 ). Yet another study argues for a subepidermal population of sessile blood cells as being the source of induced lamellocytes (Markus et al. 2009 ). Thus, one explanation of our discovery of multiple genes required for lamellocyte induction in response to wasp challenge is that different gene products may be working in distinct cell types to alter the plasticity of cells of origin to achieve the lamellocyte fate. Another possibility is that transcriptional regulators may be functioning in a combinatorial manner in the production and differentiation of the lamellocyte population.
